U.S. Markets close in 2 hrs 36 mins

iShares Core S&P Small-Cap ETF (IJR)

NYSEArca - Nasdaq Real Time Price. Currency in USD
Add to watchlist
71.2435-0.0965 (-0.1353%)
As of 1:24PM EDT. Market open.
People also watch
IJHIVVIJSIVEIJT
Full screen
Previous Close71.3400
Open71.4100
Bid71.2600 x 800
Ask71.2700 x 1400
Day's Range71.1090 - 71.4100
52 Week Range57.7150 - 72.0500
Volume729,001
Avg. Volume2,190,853
Net Assets30.58B
NAV69.03
PE Ratio (TTM)N/A
Yield1.27%
YTD Return1.08%
Beta (3y)1.05
Expense Ratio (net)0.09%
Inception Date2000-05-22
Trade prices are not sourced from all markets
  • ETF.com8 days ago

    Least Popular ETFs Of The Year

    It may be surprising to hear that in a year in which ETFs are shattering all sorts of records with regard to the amount of money they are taking in, the world's largest exchange-traded fund isn't participating in the bonanza. That's right; the SPDR S&P 500 ETF Trust (SPY), the $242 billion behemoth, has actually had net outflows this year to the tune of $4.2 billion.

  • Market Realist15 days ago

    Baxdela Is Expected to Boost Ligand Pharmaceuticals’ Revenues

    On June 19, 2017, Melinta Therapeutics announced that its drug, Baxdela, had secured regulatory approval from the FDA as a treatment option for adult patients suffering from acute bacterial skin and skin ...

  • Market Realist18 days ago

    Ligand Pharmaceuticals Projects Higher Average Royalty Rate for Promacta

    Ligand Pharmaceuticals (LGND) receives royalties from Novartis on Promacta’s sales according to a tiered annual payment structure.